Introduction {#Sec1}
============

Approximately 40,000 children from 100 countries are adopted each year in western countries \[[@CR1]\].

From 2004 to 2009, Belgian families adopted more than 2,000 children, mainly originating from China, Colombia, Russia, Philippines, India, Kazakhstan, and Ethiopia \[[@CR2]\]. The number of international adoptees has increased steadily and the countries from which children are adopted change over time \[[@CR3]\]. As a consequence, the epidemiology of diseases in this population of children shifts. International adoptees are usually under-immunized and are more exposed to infections because of crowded living conditions, malnutrition, lack of clean water and exposure to endemic diseases that are rare in western countries \[[@CR4]\]. In order to control this evolution, various countries have issued new regulations. Nowadays, all children adopted internationally by US citizens must undergo a medical examination in their country of origin by a panel of physicians designated by the US Department of State followed by a medical examination within 2 weeks of their arrival in the United States \[[@CR1]\]. In Belgium, the majority of adoptees undergo a medical examination by the Institute of Tropical Disease or by a physician with experience in adoption \[[@CR2]\]. A study on the medical evaluation of internationally adopted children has shown that worldwide, more than 50% of newly arrived adopted children were medically undiagnosed. By using various diagnostic screening techniques, an infectious aetiological agent could be detected in 73% of the children with a medical evaluation \[[@CR5]\]. Depending on the type of routine diagnosis (e.g. by direct examination, antigen detection and/or culture of the stool specimen), several studies identified an infectious etiological agent in approximately 50% of international adoptees, with parasites being the leading cause of abdominal complaints. The most common bacterial pathogens isolated on routine faecal culture include *Salmonella* spp. and *Campylobacter jejuni* \[[@CR3], [@CR6]\].

*Salmonella enterica* is a common cause of human gastroenteritis worldwide. Non-typhoid *Salmonella* infections commonly cause self-limiting gastroenteritis, but severe infections including bacteraemia, osteomyelitis and meningitis have also been reported \[[@CR7], [@CR8]\]. In general, antibiotic treatment is not required for *Salmonella* gastroenteritis unless it concerns invasive salmonellosis or affects immunocompromised patients \[[@CR7], [@CR9]\]. Although fluoroquinolones and extended-spectrum cephalosporins (ESC) are the drugs of choice to treat invasive *Salmonella*, resistance to these antibiotics is increasing worldwide \[[@CR9]\].

Since 2003, a number of studies from Europe and the United States have shown an increased number of infections, with *S. enterica* serovar Concord among Ethiopian adoptees \[[@CR10]--[@CR12]\]. Isolates associated with patients of Ethiopian origin were all multi-resistant to antimicrobials including ESC.

In Belgium, similarly, an increasing number of infections caused by *S.* Concord has been observed among children adopted from Ethiopia. This trend paralleled the rise in the number of Ethiopian adoptees since 2004.

The objective of this study was: To confirm the emergence of *S.* Concord isolates resistant to third-generation cephalosporins among Ethiopian adoptees in BelgiumTo report the disease transmission from some of these children to their adoptive families and social contactsTo provide useful information for parents adopting children and for their family practitionerTo highlight the importance of prophylactic measures and appropriate hygiene, both at school and in the social environment of the child to prevent further dissemination

Materials and methods {#Sec2}
=====================

Bacterial isolates {#Sec3}
------------------

The *Salmonella* strains isolated from patients by peripheral clinical laboratories were transferred to the National Reference Centre for *Salmonella* and *Shigella* (NRCSS) for serotyping (approximately 3,000 to 6,000 strains/year). Serotyping of strains was carried out by slide agglutination with commercial antisera according to the Kauffmann--White scheme \[[@CR13]\]. Data are registered in a database and strains are kept in collection. Data analysis allows following the epidemiological evolution of *Salmonella* isolates and when necessary to start a further characterization of isolates, as was the case with the *S.* Concord. An annual report on the activity of the NRCSS is available on <http://www.wiv-isp.be/bacterio/>

Antimicrobial susceptibility testing {#Sec4}
------------------------------------

Susceptibility to 13 antibiotics was determined in strains isolated in Belgium using the disc diffusion method (Kirby--Bauer) following recommendations of the Clinical Laboratory Standards Institute (CLSI) \[[@CR14]\]. Antibiotic disks were obtained from Biorad (Nazareth, Belgium). The antibiotics tested were: ampicillin (Amp), amoxicillin + clavulanic acid (Amx), cefotaxime (Ctx), chloramphenicol (Chl), tetracycline (Tet), nalidixic acid (Nal), ciprofloxacin (Cip), streptomycin (Str), kanamycin (Kan), gentamicin (Gen), sulfonamides (Sul), trimethoprim (Tmp), trimethoprim + sulfamethoxazole (Sxt).

Pulsed-field gel electrophoresis {#Sec5}
--------------------------------

Pulsed-field gel electrophoresis (PFGE) analysis was performed according to the PulseNet Europe protocol ([www.cdc.gov/pulsenet](http://www.cdc.gov/pulsenet)). Genomic DNA was digested with *Xba*I restriction enzymes (New-England Biolab, Leudsen, Netherlands). Braenderup H9812 digested with *Xba*I was used as a size marker.

PCR amplification of antimicrobial resistance genes and sequence analysis {#Sec6}
-------------------------------------------------------------------------

Total DNA was extracted using the InstaGene matrix kit (Biorad, 9810 Nazareth, Belgium) according to the manufacturer's recommendations. The resistance genes *bla*~TEM~, *bla*~SHV~, *bla*~OXA-1~ group and *bla*~CTX-M~ were amplified by PCR and sequenced as described previously \[[@CR15], [@CR16]\]. To characterize the molecular basis of the quinolone resistance-determining regions (QRDRs), the *gyrA*, *gyrB* and *parC* genes of isolates showing both reduced susceptibility to ciprofloxacin and resistance to Nal, were subjected to PCR amplification and subsequent sequencing. PCR amplifications specific for *qnrA, B and S* genes were also performed \[[@CR15], [@CR17]\].

Epidemiological information {#Sec7}
---------------------------

Medical records of patients with *Salmonella* Concord infections were retrospectively reviewed by linking microbiology test results with the respective medical records. The practitioners of the patients were interviewed to obtain information on the country of origin of the adoptees and their general health status. International travel, patient history and type of symptoms were also recorded, according to a standardized screening protocol \[[@CR5], [@CR6]\]. In children presenting with diarrhoea, screening for parasites on three different samples with SAF preservative \[[@CR18]\] was accompanied by culture for *Salmonella*, *Shigella*, *Campylobacter* species and *Yersinia enterocolitica*.

Results {#Sec8}
=======

Epidemiological data {#Sec9}
--------------------

Since 2004, the NRCSS observed a significant increase in the registration of *S.* Concord infections in Belgium (*p* \< 0.001; Fig. [1](#Fig1){ref-type="fig"}). Between 2004 and 2009, a total of 39 cases of laboratory-confirmed *S.* Concord infections were reported compared with only 8 cases during the period 1998--2003. Fig. 1Prevalence of *Salmonella* Concord in Belgium from 2004 to 2009

Out of the 39 cases, a total of 36 isolates were recovered from children, 30 of whom (83.4%) were adopted from Ethiopia. The age of the children ranged from 0.1 year to 5.9 years with a mean age of 0.91 ± 0.18 year. Thirty-one children (86.1%) were aged 1 year or less. In Belgium, the number of children adopted from Ethiopia increased significantly from 13.2% (62/470 international adoptions) in 2004 to 31.5% (142/451) in 2009 (*p* \< 0.001).

Of the 39 isolates, 35 isolates were available for susceptibility testing because a lack of conservation in 2004 and 2005 (Table [1](#Tab1){ref-type="table"}). Thirty-four isolates (97.1%) were considered to be multi-drug resistant (MDR) to nine or more compounds, including third-generation cephalosporins. Only one isolate recovered from a Belgian child was susceptible to all antibiotics tested. Table 1Characteristics of the *S. enterica* serotype Concord isolated since 2004YearNumber of isolatesAge (*n*)Ethiopian adoption status (*n*)Antimicrobial resistance phenotype (*n*)b-Lactam resistance gene (*n*)PFGE type (*n*)20041ChildAdoptees (1)Not testedNot testedNot tested20053ChildAdoptees (3)Not testedNot testedNot tested20066Children (5)Adoptees (2)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (2)blaCTX-M-15 (1)Xba-2 (1)blaCTX-M-15, blaTEM-1 (1)Xba-4 (1)No direct link found (2)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (2)blaCTX-M-15, blaSHV-12 (1)Xba-2 (1)blaCTX-M-15, blaSHV-12, blaTEM-1 (1)Xba-2 (1)Unkonwn (1)Amp, Ctx, Nal, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15, blaSHV-12 (1)Xba-1 (1)Adults (1)Trip (1)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15, blaTEM-1 (1)Xba-2 (1)200710Children (9)Adoptees (9)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (6)blaCTX-M-15 (3)Xba-2 (2), Xba-5 (1)blaCTX-M-15, blaSHV-12 (2)Xba-2 (2)blaCTX-M-15, blaTEM-1 (1)Xba-2 (1)Amp, Ctx, Nal, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (3)blaCTX-M-15, blaSHV-12 (3)Xba-2 (3)Adults (1)No direct link found (1)Amp, Ctx, Nal, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15, blaSHV-12 (1)Xba-2 (1)200814ChildrenAdoptees (10)Amp, Ctx, Str, Chl, Gen, Sul, Tmp, Sxt (3)blaCTX-M-15 (1)Xba-2 (1)blaCTX-M-15, blaTEM-1(1)Xba-8 (1)blaCTX-M-15,blaSHV-12, blaTEM-1 (1)Xba-1(1)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (6)blaCTX-M-15 (2);Xba-1(1), Xba-2 (1)blaCTX-M-15, blaTEM-1(2)Xba-1(1), Xba-2 (1)blaCTX-M-15,blaSHV-12, blaTEM-1 (2)Xba-4 (2)Amp, Ctx, Nal, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15, blaTEM-1 (1)Xba-3 (1)Contact with adoptees (1)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15,blaSHV-12, blaTEM-1 (1)Xba-3 (1)No direct link found (2)susceptible (1)-Xba-6 (1)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15 (1)Xba-4 (1)Adult (1)Contact with adoptees (1)Amp, Ctx, Nal, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (1)blaCTX-M-15 (1)Xba-3 (1)20095Children (5)Adoptees (5)Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt (5)blaCTX-M-15 (3)Xba-2, (3)blaCTX-M-15, blaTEM-1 (1)Xba-7 (1)blaCTX-M-15, blaTEM-1, blaSHV-12 (1)Xba-3 (1)PFGE = pulsed-field gel electrophoresis; Amp = ampicillin; Amx = amoxicillin + clavulanic acid; Ctx = cefotaxime; Chl chloramphenicol; Tet = tetracycline; Nal = nalidixic acid; Cip = ciprofloxacin; Str = streptomycin; Kan = kanamycin; Gen = gentamicin; Sul = sulfonamides; Tmp = trimethoprim; Sxt = trimethoprim + sulfamethoxazole

Five children of the 34 ESC-resistant cases were Belgian. One of them was infected through direct contact with an Ethiopian adoptee in his family in contrast to 3 other children in whom no direct link with Ethiopia could be found. There was no epidemiological information available for 1 case (Table [1](#Tab1){ref-type="table"}).

Eight children were detected as carrying *S.* Concord for a period of 1.1 to 5.2 months. All adopted children with *S.* Concord carriage were asymptomatic or presented mild abdominal discomfort. The infants were examined as they were underweight. None of them complained of diarrhoea, abdominal complaints or nausea and/or vomiting. However, respiratory tract infections were present in 6 children, hepatitis in 2, scabies in 7, Giardia in 3, a skin infection in 2 and cytomegalovirus infection in 1.

Out of the 39 cases, 3 adults were affected by the ESC-resistant isolates; 1 was a Belgian mother of an Ethiopian adoptee, 1 had travelled to Ethiopia before becoming ill, and no direct link with Ethiopia could be found for an 87-year-old person living in an care home.

Antimicrobial resistance phenotypes and genes and molecular typing {#Sec10}
------------------------------------------------------------------

The antimicrobial resistance phenotypes of 35 tested isolates are shown in Table [1](#Tab1){ref-type="table"}. The most prevalent multi-drug resistance profile was Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt. Twenty percent (*n* = 7) of the isolates conferred a full resistance to nalidixic acid (Nal) with a reduced susceptibility to ciprofloxacin (MICs between 0.5 and 1 μg/ml).

Mutations in the *gyrA* (Ser83Phe) and *parC* (Thr57Ser) were identified in three isolates with high level resistance to nalidixic acid (MICs of \>256 μg/ml). Three out of the four isolates resistant to Nal with MICs between 96 and 128 μg/ml contained the *qnrA*1 gene while the fourth one was positive for the *qnrB* gene. Furthermore, all these isolates presented a mutation in the *parC* gene (Thr57Ser).

All of the 34 ESC-resistant isolates contained the *bla*~CTX-M-15~. In addition, 12 of them were also positive for the penicillinase *bla*~TEM-1~, whereas none was positive for the penicillinase *bla*~OXA-1~. Concomitant to the *bla*~CTX-M-15,~ the *bla*~SHV-12~ gene was also detected in 14 isolates. We did not observe a shift, over time, in the extended spectrum beta-lactamase (ESBL) distribution (i.e. *bla*~CTX-M-15~ replacing *bla*~SHV-12~) as has been observed in other countries \[[@CR12]\].

Clonal relationship of the 35 isolates was assessed by pulse-field gel electrophoresis of *Xba*-I-digested chromosomal DNA (Fig. [2](#Fig2){ref-type="fig"}). Eight different PFGE profiles were obtained. No link between the PFGE profile and the β-lactam resistance gene type could be found. Among the dominant *Xba*-2 profile (*n* = 19), 8 isolates harboured the *bla*~CTX-M-15~ gene, 7 produced the *bla*~CTX-M-15~ in combination with *bla*~SHV-12~, 3 produced *bla*~CTX-M-15~ and *bla*~TEM-1~and 1 isolate produced, *bla*~CTX-M-15~, *bla*~SHV-12~ and *bla*~TEM-1~simultaneously. Fig. 2Representative Xba-I pulsed field gel electrophoresis (PFGE) profiles of *S. enterica* serotype Concord isolates studied. A dendrogram was generated with Bionumerics software. The PFGE profile and number of isolates are indicated

Among the 5 cases for which no direct epidemiological link with Ethiopia could be found by interviews, 1 isolate was susceptible to all antibiotics tested and presented a completely different PFGE profile (Xba-6) (Fig. [2](#Fig2){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}). The four other isolates presented the common multidrug resistance profile Amp, Ctx, Str, Chl, Gen, Tet, Sul, Tmp, Sxt. In one isolate, this MDR profile was associated with Nal resistance. These isolates also displayed the common Xba-2 PFGE (*n* = 3) and Xba-4 PFGE profiles (*n* = 1), strongly suggesting a phylogenetic relationship with the Ethiopian isolates.

Discussion {#Sec11}
==========

Since 2004, Belgian families have adopted 655 children from Ethiopia. In 2009, they represented 31.5% of the internationally adopted children in Belgium. Ethiopia is one of the poorest countries in Africa with more than 4.5 million orphans and according to a recent study, intestinal parasites are commonly found in Ethiopian adoptees \[[@CR19], [@CR20]\]. *Giardia lamblia* was the most frequent pathogen isolated in this population, but because of an improper diagnosis procedure less is known about the other intestinal infectious diseases, including salmonellosis \[[@CR20]\]. During the last decade, an increased incidence of *Salmonella* Concord infection among Ethiopian adoptees was noted in western countries \[[@CR10]--[@CR12]\]. This increasing incidence was also noted in our study. Indeed, 39 cases of *S.* Concord were notified in the period 2004--2009 against only 8 cases in the period 1998--2003. As in the other studies, a huge diversity of the PFGE patterns (8 patterns/35isolates) was observed among these isolates, indicating an endemic problem in Ethiopian orphanages. Most of the isolates showed multiple antibiotic resistance. In addition to ESBL production, 20% of the isolates displayed a resistance to nalidixic acid associated with a decreased susceptibility to ciprofloxacin. Fluoroquinolones are the drugs of choice for an invasive extra-intestinal infection in adults whereas ESC are preferentially used to treat salmonellosis in children. Resistance to ESC is a point of concern as the majority of the *Salmonella* Concord isolates was detected in children \<5 years. Moreover, even a decreased susceptibility to fluoroquinolones has become a major problem in the treatment of patients infected by *Salmonella* isolates, as has been reported by Aarestrup et al. \[[@CR21]\]. It is obvious that the problem is not limited to the introduction and dissemination of a possible exotic pathogen, but also comprises the introduction of antibiotic resistance determinants. Subsequently, these determinants can be transferred by horizontal genetic flux to the normal flora and other pathogenic bacteria. Eventually, this dissemination will jeopardize classical antibiotic treatments in patients at risk. This study confirmed the risk of contamination of the adoptee's entourage. Intra-familial transmission has been documented with variable transmission rates for different bacterial pathogens \[[@CR22]--[@CR24]\]. Parents of adoptees are at risk of both travel-related illnesses and infectious organisms carried by their adopted child. Other family members who did not travel may also be at risk through subsequent contact with the child \[[@CR4]\]. We found this type of isolate in an elderly patient and in 4 children without any apparent link to Ethiopia. Even if the frequency of the transmission seems to be very low, this finding highlights the risk of a possible dissemination of these isolates in the general population. The extensive colonization time is another factor that may explain this dissemination of the *Salmonella* Concord. Our study has shown that adopted children can be carriers for a number of months. However, asymptomatic children who excrete an entero-pathogen usually do not need to be excluded from day care \[[@CR25]\]. Nevertheless, it is important to recommend a systematic stool culture to screen for bacterial pathogens including *Salmonella*, even for asymptomatic adopted children. Families and close contacts of the respective children have to be informed of the risk of contamination and the preventive measures that should be taken.

A major problem concerns underestimation, both on the clinical and microbiological level, of the cases of microbial pathogens introduced by internationally adopted children. Indeed, in our study period we only received 30 isolates out of a total of 655 Ethiopian adoptees. In Belgium it is recommended that every child adopted from abroad undergoes a medical evaluation using simple screening tests following international recommendations \[[@CR5], [@CR6], [@CR17]\]. The non-obligatory character of this test explains the fact that a lot of cases remain undiagnosed. Screening for ova and parasites is only requested for children with diarrhoeal symptoms using the triple-faeces test in which three stool samples, collected on 3 consecutive days, are examined according to a concentration technique and permanent staining. However, the screening should be systematic and could be enlarged to *Salmonella*, *Shigella*, *Campylobacter* spp., *Yersinia enterocolitica* and other infectious disease. It is clear that adoption can be a contributing factor in the spread of multi-drug resistance. Therefore, it is of utmost importance to perform a systematic screening for antimicrobial resistance, especially when adopted children come from countries known for a high prevalence of multi-resistance. Parents should be stimulated to follow conscientiously the recommendations implemented to give the adopted children access to the best possible medical care.

Specific infection control strategies for households and community include meticulous hand washing and stringent sanitary procedures for toilet use and toilet training. These hygiene rules are especially important in diapered incontinent children. The risk of food contamination increased when people who care for diapered children also prepare or serve food as shown in some reports of *Salmonella* outbreaks in childcare programs \[[@CR26]\]. Our study highlights the importance of prophylactic measures and appropriate hygiene, both at school and in the social environment of the child in order to prevent further dissemination. Competent authorities play a key role, not only in controlling the implementation of hygienic rules at the level of day care centres, but also in supplying practical information to the social environment of the future adoptee. Leaflets concerning the possible risk of infectious diseases, their transmission and impact on public health, and practical measures to contain this problem are more than welcome. Adequate information and well thought-out practical protocols should be made available to the medical community involved in the follow-up of adopted children. Parents adopting children (especially from Ethiopia) and their general practitioners should be extensively informed of the possible infectious risks and the way to handle these risks.

Finally, we should realize that containment of the problem needs an international approach. International health care and educational organisations can support campaigns for vaccine-preventable diseases. Their financial support and logistic interventions will not only ameliorate the basic hygienic conditions in the orphanages, but will also have an impact on the sanitary situation in the countries of origin.
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